Breaking News Headlines Today

News from european-biotechnology.com

All of today’s top news stories from European-biotechnology.com. Get the full analysis behind how media bias impacts breaking news.

In total, 72 have been published by European-biotechnology.com which Ground News has aggregated in the past 3 months.

The Ground News media bias check for European-biotechnology.com is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

If you want to know if European-biotechnology.com is credible or reliable, look no further. We rank European-biotechnology.com as Unknown factuality. Find out more about our methodology here.

Information about European-biotechnology.com

Where is European-biotechnology.com located?European-biotechnology.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Fine and speciality chemicals industry keeps its cool - European Biotechnology Magazine

Resilience and quality connections define Chemspec Europe 2025. The post Fine and speciality chemicals industry keeps its cool appeared first on European Biotechnology Magazine.Read Article

One Bioscience raises €15m to leverage AI tumour profiling - European Biotechnology Magazine

Paris-based One Biosciences, a pioneering "techbio" company at the intersection of artificial intelligence and oncology, has announced a €15 million Series A funding round to accelerate the clinical application of its flagship technology. The post One Bioscience raises €15m to leverage AI tumour profiling appeared first on European Biotechnology Magazine.Artificial Intelligence · Paris Read Article

Clinical data meet preclinical validation: Axxam´s partnership with Molecular Health - European Biotechnology Magazine

That deserves a closer look: The recently announced partnership between Axxam S.p.A., a leading provider of integrated early discovery services, and Molecular Health GmbH, a pioneer in AI-powered data solutions for pharmaceutical R&D, is more than a standard collaboration. It exemplifies the convergence of consolidated in-vitro biology-led drug discovery with modern, data-intelligent drug development methodologies. As an example for breaking the…Germany · Germany Read Article

Dual Antibody-Drug Conjugates Developed to Target Multiple Cancer Cell Markers

A recent report highlights advancements in dual antibod […]European Union · Spain See the Story

Spain’s Biotech: Growth, Impact and Global Role - European Biotechnology Magazine

Spain’s biotech sector drives innovation, economic growth, and scientific excellence. With strong R&D investment, global research impact, and a leading role in gender equality, it’s a key player in health, sustainability, and strategic autonomy. BIOSPAIN 2025 in Barcelona will showcase its potential and connect global biotech leaders. The post Spain’s biotech: growth, impact and global role appeared first on European Biotechnology Magazine.Health · Barcelona See the Story

AmphiStar: €12.5m EIC Funding to Advance Commercialisation of Bio-Based Surfactants - European Biotechnology Magazine

The new funding includes €2.5m grant and €10m equity investment and supports Belgian AmphiStar’s potential to reshape the surfactants market. This investment will accelerate scale-up and market entry of sustainable biosurfactants, which AmphiStar has already set up transatlantic in a recent partnership. The post AmphiStar: €12.5m EIC Funding to Advance Commercialisation of Bio-Based Surfactants appeared first on European Biotechnology Magazine.Belgium · Belgium Read Article

Sino Biological Sets New Industry Standard with ProPure™ Endotoxin-Free Proteins - European Biotechnology Magazine

Sino Biological US, Inc. proudly unveils ProPure™, an industry-leading line of ultra-pure, endotoxin-free recombinant proteins, fully produced in the USA at its state-of-the-art Center for Bioprocessing (C4B) facility in Houston, Texas. The post Sino Biological Sets New Industry Standard with ProPure™ Endotoxin-Free Proteins appeared first on European Biotechnology Magazine.Houston, Texas · Houston Read Article

News from european-biotechnology.com

News from european-biotechnology.com